Clinical Trial Update: Celecoxib as a Chemopreventive Agent in Current and Former Smokers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating celecoxib as a chemopreventive agent in current and former smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Smoking, Prevention | Phase 3 | Status: COMPLETED